Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add filters








Language
Year range
1.
Korean Journal of Dermatology ; : 687-690, 1994.
Article in Korean | WPRIM | ID: wpr-206884

ABSTRACT

Trichoblastic fibroma is a rare benign tumor of hair germ with mixed epithelial-mesenchymal components. A 64-year-old female presented with an asymptomatic, skin-colored, firm nodule on the left knee joint. Histopathologic examination showed multiple tumor islands and strands eomposed of basaloids cells embedded in a moderately cellular fibroblastic stroma and the for vation of bud-like extension of tumor cell nest. The peripherel basaloid cells shovred a palisading arrangement and small keratinous cysts were formed in tumor islands.


Subject(s)
Female , Humans , Middle Aged , Fibroblasts , Fibroma , Hair , Islands , Knee Joint
2.
Korean Journal of Dermatology ; : 703-706, 1994.
Article in Korean | WPRIM | ID: wpr-206881

ABSTRACT

Chloramphenicol ophthalmic solut,ion is a commonly used eye drui in the treatment of superficial eye infection because of its wide antibacterial spectrum and easy peitation in the ocular tissue and aqueous humor. The true contact dermat it is to chloramphenicol is rarely reported. A case of contact. dermatii,is due to chloramphenicol in a 6-year-old girl was confirmed by the patch test. Marked improvement of the skin lesion and symptoms were rated after the withdrawal of topieal application of the chloramphericol ophthalmic solution.


Subject(s)
Child , Female , Humans , Aqueous Humor , Chloramphenicol , Dermatitis, Contact , Eye Infections , Patch Tests , Skin
3.
Korean Journal of Dermatology ; : 1054-1063, 1994.
Article in Korean | WPRIM | ID: wpr-69644

ABSTRACT

BACKGROUND: Calcipotrol, topical vitamin D analogue, has been demonstrated to have an effect for the treatment of psoriasis with good tolerability. It is required to have comparative studies with the other topical agents which are widely used for the treatment of psoriasis. OBJECTIVE: Our purpose is to compare calcipotriol with desoxymethasone ointemtn in their therapeutic efficacy and ability to affect dermal inflammatory cellular events. METHODS: This study was a randomized, double blind, right/left comparison over 8weeks in 10 patients. The ointments were applied twice daily to the lesions of psoriasis. Clinical efficacy, as measured by the Psoriasis Area and Severity Index(PASI) was assessed at 2, 4, 6 and 8weeks after starting treatments. The changes in the numbers of dermal immunocytes were assessed on frozen and paraffin-embedded sections by using immunohistochemical stain methods before and after the treatemtns. RESULTS: Reduction of PASI was statistically significant at all time points for both of the treatments (P<0.01) but there was no significant defference between the two treatment modalities. At the completion of 8 weeks of treatments, the mean PASI reduction was 65 percents and 67 percents for calcipotriol and desoxymethasone ointments, respectively. On immunohistochemical staining, the numbers of LCA and HLA-DR positive cells were decreased significantly(P<0.05), and IL-2R and CD4 positive cells were not significaltly reduced in each group after the treatment. CONCLUSION: Calcipotriol ointment was as effective as desoxymethasone ointment, judged by the PASI and the dermal inflammatory cellular events on immunohistochemical staining.


Subject(s)
Humans , Dermatitis, Atopic , Desoximetasone , HLA-DR Antigens , Ointments , Psoriasis , Vitamin D
4.
Korean Journal of Dermatology ; : 802-808, 1994.
Article in Korean | WPRIM | ID: wpr-91482

ABSTRACT

BACKGROUND: It is well-known that the giant congenital nevi prcgress to malignant, melanama more frequently than other benign melanocytic nevi but to date the laor tory methods for early detection of such progression were not avsilable. The proliferating cell uncleai antigen(PCNA) staining has been regsrded as an useful marker in determining prognosis of some maignant diseases. OBJECTIVE: The PCNA taining was performed as a predictive value of malignant transformation from benign meanocytic skin lesions. We investigated the differcnces between malignant melanoma and the benign lesions. MATERIAL AND METHODS: Immunohistochemical study was employee using anti-PCNA, anti-S-100, and anti-CD45RO antibody in 6 giant congenital nevi, 8 small and medium sized congenital nevi, 10 acquired nevi, and 10 malignant meanomas. Only cells positive for both PCNA and S-100, and negative for CD45RO on the serial sections were identified as melanocyts. RESULTS: The number of PCNA-posit,ive cells per 1000 melanocy,es averaged 6.0+7.5 in giant, congenital nevi, 2.9+1,9 in small and medium sized congenital novi, 3.1+2.7 in acquired nevi, and 61.5+ 39.4 in malignant, melanomas. Malignant melanomas showed onger intensity of PCNA staining than the other melanocytir nevi. CONCLUSION: There was not significant difference of the numter of PCNA-positive cells among the groups of congenital neviind PCNA staining can't be used in prditive measure of malignant. progression and studying mechansm of malignancy in giant congenital nevi. But, PCNA staining is considered as an useful method in differentiat,ing malignant melanoma from mllanocytic nevi.


Subject(s)
Melanoma , Nevus , Nevus, Pigmented , Prognosis , Proliferating Cell Nuclear Antigen , Skin
5.
Korean Journal of Dermatology ; : 829-934, 1993.
Article in Korean | WPRIM | ID: wpr-101004

ABSTRACT

Higt energy electron beam therapy is a method which is used for the treatment of superficial tumors (less than 5 cm deep) with a characteristically sharp drop-off in dose beyond the tumor. This method offers distinct advantages in dose uniformity and in minimizing the dose to deeper tissues. We report herein three cases of epithelial skin cancer treated with high energy electron beam. The first patient was a 79-year-old male who had primary basal cell carcinoma(BCC) on the right lateral canthus. The second patient was a 67-year-old male who had recurreiit BCC on the right cheek. Both of them received electron beam therapy on the lesion and there were no clinical relapse signs over 1 year. The third patient was a 46-year-old male who had squamous cells, carcinoma on the lower lip. He also received electron beam therapy on the lesion, but it recurred.


Subject(s)
Aged , Humans , Male , Middle Aged , Carcinoma, Basal Cell , Carcinoma, Squamous Cell , Cheek , Lip , Recurrence , Skin Neoplasms , Skin
SELECTION OF CITATIONS
SEARCH DETAIL